Latest / Pharmacy Podcast Network / Nebraska Pharmacy Owner Has Found Practical Way To Profitably Fill Branded Rx's | Pharmacy Crossroads
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession Welcome to the Pharmacy podcast Network.
- 0:22Speaker 2: This is Pharmacy Crossroads with your host, community pharmacy business
- 0:27Speaker 2: veteran the road trip goth Bruce naland community pharmacy is
- 0:33Speaker 2: at a crossroads. Pharmacy owners across the country are evolving
- 0:37Speaker 2: their pharmacy businesses and making a bigger impact on their communities.
- 0:41Speaker 2: Bruce talks with the most innovative community pharmacy owners, pharmacy
- 0:45Speaker 2: industry experts, and people who are passionate about the business
- 0:49Speaker 2: of pharmacy and its impact on community healthcare. Pharmacy Crossroads
- 0:53Speaker 2: is a member of the Pharmacy Podcast Network. And now
- 0:57Speaker 2: here's our host, Bruce Neeland.
- 1:00Speaker 3: Well, hello again, ladies and gentlemen, friends and neighbors, pharmacies professionals,
- 1:05Speaker 3: and anybody else who's listening. This is Bruce Neland bringing
- 1:10Speaker 3: you another episode of Pharmacy Crossroads. It's a joy to
- 1:14Speaker 3: be here with you today, and I'm telling you I'm
- 1:17Speaker 3: excited about talking to this gentleman who I have met
- 1:22Speaker 3: through an industry colleague. Jed and I don't know each
- 1:26Speaker 3: other except for a five minute phone call getting ready
- 1:29Speaker 3: to do the podcast. But Jed is a pharmacist who
- 1:33Speaker 3: has found a way to fill prescriptions and actually make money.
- 1:41Speaker 3: So we're going to jump into that and let him
- 1:44Speaker 3: explain how that happens. To be clear, it's a handful
- 1:47Speaker 3: of prescriptions that he fills. He might fill a dozen
- 1:51Speaker 3: or two a month, where his gross profit is one
- 1:54Speaker 3: hundred dollars or more per prescription. And I'm hoping that
- 1:58Speaker 3: that's enough of a ring to get you to stay
- 2:01Speaker 3: on and listen to what Jed has to say. So,
- 2:05Speaker 3: Jed Lewis, tell us a little bit about who you
- 2:09Speaker 3: are and what your pharmacies are like and where they are.
- 2:13Speaker 4: Yeah, I have I have four pharmacies in Nebraska.
- 2:18Speaker 5: We have one in the.
- 2:22Speaker 4: Omaha metro area that it fights with Walgreens in the
- 2:26Speaker 4: major grocery chains and cvs every day. And then I've
- 2:29Speaker 4: got three rural stores. Two do really really well in
- 2:34Speaker 4: smaller communities, and then one is a telefarm. We passed
- 2:38Speaker 4: the telefarm build all a few years back and we
- 2:41Speaker 4: converted to tell pharmacy. It treads water, but it holds
- 2:45Speaker 4: its own stand above in the black just barely. But anyways, Yeah,
- 2:53Speaker 4: we have four pharmacies. We grind every day like everybody else.
- 2:57Speaker 4: We're true retail stores. And that's pretty much out.
- 3:01Speaker 3: Well, and I wanted to ask a little bit more
- 3:04Speaker 3: about that. So these are real pharmacies in the real world,
- 3:08Speaker 3: and these prescriptions that you're filling are for real regular people.
- 3:12Speaker 3: You're not contracted with a mental health facility or something
- 3:16Speaker 3: like that that's making this attractive profit margin possible.
- 3:20Speaker 5: Right, No, true standard retail.
- 3:24Speaker 4: We don't have any special, super secret contracts or anything
- 3:28Speaker 4: like this. And we can get into it a little
- 3:29Speaker 4: bit later. But we took a flyer on a drug
- 3:31Speaker 4: rep that walked in.
- 3:33Speaker 3: I guess it is time to get into that. What
- 3:35Speaker 3: company are you working with? And how did you find them?
- 3:41Speaker 4: The company is Biopharma, and they kind of found me.
- 3:46Speaker 5: They were.
- 3:48Speaker 4: Basically some of these smaller pharmaceutical companies aren't or Walgreens
- 3:54Speaker 4: and CBS, major grocery change. They're just too big. They
- 3:58Speaker 4: won't work with they won't fly, they won't bend. We're
- 4:01Speaker 4: an independent pharmacy, you know. I got told this a
- 4:05Speaker 4: while ago. Some of these bigger companies are like a
- 4:08Speaker 4: cruise ship. It takes them a while to turn the
- 4:09Speaker 4: ship where we're more of a speedboat and we can
- 4:14Speaker 4: turn and go fast quickly. And so, you know, there's
- 4:18Speaker 4: some unique opportunities that have kind of come up over
- 4:21Speaker 4: the years. Some we've done well on and some we've
- 4:24Speaker 4: just you know, they've kind of fizzled out.
- 4:26Speaker 5: We took we took a shot.
- 4:28Speaker 4: Doug Goodwin, the Duck drug rep, came in one day
- 4:30Speaker 4: and told me about his product, that Biopharma, and they
- 4:34Speaker 4: have a unique portfolio of meds, some of them A
- 4:37Speaker 4: lot of people here the oxy codone and they get
- 4:41Speaker 4: gun shy right that that is one of the products
- 4:45Speaker 4: or prolate, which is a it's an oxy codone two
- 4:49Speaker 4: and a half three hundred five three hundred seven and
- 4:52Speaker 4: a half three and ten three hundred. One of the
- 4:56Speaker 4: things Biofarma does really well is they they've carved out
- 5:00Speaker 4: what I would call tweener drugs, and they also have
- 5:04Speaker 4: some ursa dile in there, the two hundred and four
- 5:08Speaker 4: hundred that are you know, again offshoot.
- 5:12Speaker 3: Don't let me let me stop there, because that tweener
- 5:15Speaker 3: word came pretty quick. Tweener as in the in between.
- 5:20Speaker 3: So there are drugs that are fitting in a gap
- 5:23Speaker 3: between other drugs. Correct correct, Okay, go ahead.
- 5:27Speaker 5: Yeah, so you know I told I told the drug graph.
- 5:31Speaker 4: Yeah, well, you know I won't stnk it, but if
- 5:34Speaker 4: you get me a couple of prescriptions from a doctor,
- 5:36Speaker 4: we will we have no problem filling it. Basically doing
- 5:43Speaker 4: some research, it was basically similar to percoset. I mean
- 5:47Speaker 4: very very very close to percoset. The you know, it
- 5:50Speaker 4: is a branded medication, but they offer it generic. Now
- 5:54Speaker 4: most of the most of the products we run from
- 5:58Speaker 4: them are their generic shoot and they pay very, very
- 6:03Speaker 4: very well. You indicated that it was one hundred dollars.
- 6:06Speaker 4: It's you can multiply that by ten. Usually we're averaging
- 6:11Speaker 4: about fifteen hundred dollars net per prescription. Now again I
- 6:17Speaker 4: was not I said we'd take a chance if we
- 6:21Speaker 4: got a script.
- 6:22Speaker 5: We got a script.
- 6:23Speaker 4: One of the things they were doing in the early
- 6:24Speaker 4: stages was there was this nalloset which is there two
- 6:28Speaker 4: and a half three hundred, and they had a coupon
- 6:31Speaker 4: to go with it where if it didn't get approved
- 6:35Speaker 4: and every one of these drugs are going to need
- 6:36Speaker 4: a PA and I can go into.
- 6:39Speaker 5: That in a little bit later, but.
- 6:41Speaker 4: The coupon was either fifteen or thirty dollars anywhere from
- 6:46Speaker 4: a fifteen day supply to a thirty day supply, So
- 6:51Speaker 4: it allowed you to work on the PA in the
- 6:53Speaker 4: background where they got their medication. The doctors really did
- 6:58Speaker 4: like that two and a half three hundred, because a
- 7:00Speaker 4: lot of docs don't want to you know, they don't
- 7:02Speaker 4: want to start anybody on oxy unless you know absolutely necessary.
- 7:10Speaker 4: That being said, we we got a couple of scripts
- 7:13Speaker 4: to go through and the PA to go through, and
- 7:16Speaker 4: what I found out was the profit margin was insatan
- 7:20Speaker 4: the two and a half three hundred, and I felt
- 7:23Speaker 4: stupid at first because I didn't know they had a
- 7:26Speaker 4: generic line on the backside. We had been running the
- 7:29Speaker 4: brand for six to eight months and we were making
- 7:33Speaker 4: anywhere from two hundred to two hundred and fifty dollars
- 7:36Speaker 4: a script, which you know you make anywhere from one
- 7:39Speaker 4: hundred to three hundred.
- 7:40Speaker 5: Dollars to script. That's incredible.
- 7:42Speaker 4: Well, then I found out they had a generic, and
- 7:47Speaker 4: so we started running the generic and that profit.
- 7:52Speaker 5: It got exponentially better.
- 7:55Speaker 3: The JOD would To be clear, you're talking about regular
- 8:00Speaker 3: brand name. Percocet has a generic, an exact equivalent.
- 8:05Speaker 4: ANALYSI that is there two and a half three three
- 8:08Speaker 4: hundred line or oxy coote on two and a half
- 8:10Speaker 4: last three hundred to seedo menafin. And then their prolate
- 8:13Speaker 4: line is the five three hundred, seven and a half
- 8:17Speaker 4: three hundred ten three hundred of oxy.
- 8:21Speaker 3: Okay, and that's the Biolifeline, which, by the way, to
- 8:25Speaker 3: be clear with my listener's biolife as I have come
- 8:29Speaker 3: in contact with them here in the last year, has
- 8:32Speaker 3: changed their name to FH two Pharma, and we'll get
- 8:37Speaker 3: you in a website address on them towards the end
- 8:41Speaker 3: of the program. But I've interrupted you when you were
- 8:44Speaker 3: just when you were on a real role, and I'm sorry,
- 8:47Speaker 3: but I want to make sure that when you're talking
- 8:48Speaker 3: about the generics per percocet, you are talking about the
- 8:53Speaker 3: FH two Pharma product portfolio, correct, gotcha?
- 8:57Speaker 5: Gotcha? Yes? And you know to me they're one and
- 9:01Speaker 5: the same.
- 9:02Speaker 4: But anyways, when you start working with it, it's a
- 9:06Speaker 4: tomato tomato. So anyways, we got going and then we
- 9:09Speaker 4: ran a generic and it popped, and to our surprise,
- 9:13Speaker 4: we netted sixteen hundred dollars on that first prescription. Then
- 9:16Speaker 4: I was a believer. So then we started just mining
- 9:19Speaker 4: our own data.
- 9:20Speaker 5: We didn't do it.
- 9:20Speaker 4: We weren't actively going to doctors or doing anything exciting.
- 9:25Speaker 5: We didn't.
- 9:25Speaker 4: You know, I'm sure some of your listeners have maybe
- 9:28Speaker 4: seen the Netflix shows or the Oxy Kittens and in
- 9:33Speaker 4: some of the ways that the Sacler Boys utilized their
- 9:36Speaker 4: reps to go out.
- 9:39Speaker 5: Yeah, no, we didn't do anything exciting.
- 9:41Speaker 4: All we did is we just we We did a
- 9:43Speaker 4: simple data analysis on our own data in our stores
- 9:47Speaker 4: and found out we had x amount of patients that
- 9:49Speaker 4: were on percocet, and then within that x amount of
- 9:53Speaker 4: patients there was the dual eligibles were generally the easiest
- 9:57Speaker 4: to convert.
- 10:00Speaker 5: So the people on.
- 10:03Speaker 4: Optum or United Healthcare do eligible plans, they would almost
- 10:09Speaker 4: took very little effort on that prioritization, and they are
- 10:13Speaker 4: also our best payer. So then what we were doing
- 10:18Speaker 4: is we also run a dual eligible or combo shop
- 10:22Speaker 4: where we have the Jerry met in our system.
- 10:25Speaker 5: Also a lot of these people, a lot of them
- 10:28Speaker 5: are home.
- 10:29Speaker 4: To home where we would deliver the meds to them
- 10:33Speaker 4: or mail the meds to them, and we would you know,
- 10:37Speaker 4: this is also in the d R days, we would
- 10:39Speaker 4: trim the d R and save another five six hundred
- 10:42Speaker 4: dollars by limiting that dr fee by running it.
- 10:46Speaker 5: Through jerryman So and then to dovetail out that and
- 10:52Speaker 5: I get.
- 10:53Speaker 4: I know your listeners are probably like, oh my god,
- 10:54Speaker 4: these guys are these guys are out there. You indicated
- 11:00Speaker 4: early in the show we were just a handful of
- 11:01Speaker 4: scriptions prescriptions our average across my four stores, and we do.
- 11:08Speaker 5: I just did the numbers the other day.
- 11:10Speaker 4: We do about two hundred and eighty thousand scripts a
- 11:12Speaker 4: year across our four stores. My little telepharmacy store does
- 11:16Speaker 4: about twenty thousand scripts a year.
- 11:17Speaker 5: My Skylar.
- 11:20Speaker 4: Rural store does about forty five fifty thousand scripts a year.
- 11:23Speaker 5: My bigger store where I'm at right now and.
- 11:25Speaker 4: Wahou does roughly one hundred thousand scripts, and in our
- 11:28Speaker 4: Omaha Metro store does about eighty thousand scripts.
- 11:32Speaker 5: Out of those scripts.
- 11:34Speaker 4: Combined, we do roughly twenty to twenty five prolates or
- 11:40Speaker 4: analysts or biopharma drugs a month.
- 11:44Speaker 5: So there's not a lot.
- 11:46Speaker 4: There, but the amount that is there is very, very
- 11:50Speaker 4: very lucrative for us, and it helps mitigate a lot
- 11:56Speaker 4: of these losses on the Manjarros EOZMPEX, the golp ones.
- 12:00Speaker 4: They're losing twenty scripts or a tricare well, I.
- 12:03Speaker 3: Mean doing the rough numbers, twenty scripts a month of
- 12:06Speaker 3: one thousand dollars gross propit. That's twenty thousand a month, right.
- 12:11Speaker 4: That's correct, And it's actually more than that. They're you know,
- 12:15Speaker 4: I don't want to really get into the weeds, but
- 12:17Speaker 4: some of the are worth a lot more than the thousand.
- 12:22Speaker 4: So that being said, we average about fifteen hundred dollars
- 12:28Speaker 4: a script on those scripts.
- 12:30Speaker 5: Across the board. So yeah, well, but.
- 12:35Speaker 3: Back up a little bit. You talked in the beginning
- 12:38Speaker 3: about meeting a drug rerapid detail guy.
- 12:42Speaker 5: Right, yeah, a couple. So I think I've been We've
- 12:47Speaker 5: had a relationship.
- 12:48Speaker 4: We've been doing this for I believe a year and
- 12:50Speaker 4: a half, almost two years now, And before Doug, before
- 12:55Speaker 4: I met Doug, I had met a couple of girls
- 12:57Speaker 4: that were pushing to jail and they were family. One
- 13:02Speaker 4: of the gals was a family friend from where I
- 13:04Speaker 4: grew up up in northeast Nebraska, and one of the
- 13:09Speaker 4: things that I learned with she asked me to come
- 13:12Speaker 4: along to a drug talk with her, and I didn't
- 13:14Speaker 4: have anything going on during the day, and I went.
- 13:17Speaker 4: This was five years ago, and so I went with
- 13:19Speaker 4: her and not knowing you know anything or you know
- 13:22Speaker 4: what they do, or you know, we hear drug reps
- 13:24Speaker 4: are bad and blah blah blah. But one thing I
- 13:27Speaker 4: learned from the drug rep side is there trained how
- 13:32Speaker 4: to get past that front window or front desk at
- 13:36Speaker 4: the doctor's office and to get into that back room
- 13:39Speaker 4: and get you know, twenty to fifteen minutes with the doctor. Well,
- 13:45Speaker 4: she brought me back and I was, you know, when
- 13:48Speaker 4: you're a patient, you just go back.
- 13:49Speaker 5: And sit in the room and twiddle your thumbs and
- 13:51Speaker 5: wait till you be you're seeing.
- 13:53Speaker 4: Well in the doctor's room, you know, they have the
- 13:55Speaker 4: lunches and what have you on. And I'm sitting there
- 13:57Speaker 4: and I'm bsing with the nurses and how you doing
- 14:01Speaker 4: this is who I am?
- 14:02Speaker 5: Blah blah blah. And then the doc comes in.
- 14:04Speaker 4: She introduces herself and she said, hey, I've brought a friend,
- 14:07Speaker 4: one of my buddies that owns a pharmacy. He stopped
- 14:11Speaker 4: and carved out forty five minutes and we talked and
- 14:14Speaker 4: just yucked it up about the industry, what they do,
- 14:17Speaker 4: where they're deficient. What were he's struggling with what we
- 14:21Speaker 4: could do to help. It turned into a relationship that
- 14:24Speaker 4: all of a sudden he didn't He was getting fed
- 14:27Speaker 4: up with the CBS's and the Walgreens of the world,
- 14:29Speaker 4: and not saying that they have bad pharmacies, it's just
- 14:32Speaker 4: sometimes they've they're just constricted because they're a big ship
- 14:35Speaker 4: and they got corporate rules and responsibilities where they can't
- 14:38Speaker 4: flex as much.
- 14:41Speaker 5: Long story short, he started turfing a ton of patients
- 14:43Speaker 5: my way, and.
- 14:44Speaker 4: I really quickly understood the value of the relationship of
- 14:48Speaker 4: a drug rep. Don't turn them off, you know, and
- 14:53Speaker 4: then you start realizing there's some better than others. Well,
- 14:56Speaker 4: then I started going along to lunches with the drug.
- 14:58Speaker 4: Whenever I had free time, I go to different doctors.
- 15:01Speaker 4: And it was a cheap, easy way for me, you know,
- 15:04Speaker 4: because the independent pharmacy resources are thin. Well, somebody who
- 15:08Speaker 4: does have a lot of resources are the drug companies
- 15:10Speaker 4: and their drug reps, and they got a credit card
- 15:12Speaker 4: that is easily buying lunches, and they're trying to get
- 15:15Speaker 4: past that front window.
- 15:17Speaker 5: We were so long.
- 15:19Speaker 4: Story short, Over the last four or five years, I
- 15:21Speaker 4: have created quite the rapport with doctors around the metro
- 15:25Speaker 4: and the rural area through the drug reps. So when
- 15:29Speaker 4: Doug came in, I kind of like raised an eyembron
- 15:31Speaker 4: because it was oxy. I said, I'll give it, I'll
- 15:33Speaker 4: give it a chance. Well, next thing you know, he's
- 15:38Speaker 4: he got me a script. I saw the results of
- 15:40Speaker 4: the script and I was like, okay, we can Well, yeah,
- 15:43Speaker 4: we'll carry this.
- 15:44Speaker 5: So yeah, it's been it's been a neat relationship.
- 15:48Speaker 4: The one thing I like most and again I need
- 15:51Speaker 4: to stress this because I know people are still you know,
- 15:56Speaker 4: the stigma in the oxy is there is there's it's
- 16:00Speaker 4: it's a bad thing. The opioid epidemic is real. But
- 16:06Speaker 4: one of the things that's unique about the pain person
- 16:10Speaker 4: is you can almost set your watch to when they're
- 16:12Speaker 4: going to come into the store. They're almost like an
- 16:15Speaker 4: HIV person where they're religiously filling every twenty eight to
- 16:19Speaker 4: thirty days, and so you can stock, you can manage
- 16:22Speaker 4: correctly the inventory.
- 16:25Speaker 5: It's it's actually great.
- 16:27Speaker 4: And then one thing we've done to augment our business
- 16:30Speaker 4: on top of this is nobody's just on an oxy pill.
- 16:34Speaker 4: They're also on blood pressure medication. They may be on
- 16:39Speaker 4: you know, diabetes medications. So then we started gaining more
- 16:42Speaker 4: business and medsinking. And now we've gained rapport with some
- 16:45Speaker 4: of these pain docs who aren't just doing oxy, they're
- 16:48Speaker 4: doing subox own and some other stuff. So that is
- 16:51Speaker 4: generated We've increased our business ten to fifteen percent just
- 16:55Speaker 4: by the rapport of these doctors. And all you can
- 16:58Speaker 4: medsync them and that you watch to them and use
- 17:01Speaker 4: them as your anchormeds and then augment that you know,
- 17:05Speaker 4: portfolio of that patient and mail out or ship or
- 17:09Speaker 4: get everything lined up and easily you know, cash slow them.
- 17:13Speaker 3: So anyways, let me interrupt because you've said three things
- 17:18Speaker 3: to this point that have you stand out in my
- 17:21Speaker 3: mind about you and your practice. Number One, he says,
- 17:25Speaker 3: you spend time looking at the data with the PBMs
- 17:28Speaker 3: and horsing around trying to figure out how you can
- 17:31Speaker 3: move things around it, you know, to save some money
- 17:34Speaker 3: or whatever. And my suspicion is that it's reasonably common,
- 17:38Speaker 3: but I don't think it's universally common. And that's just
- 17:42Speaker 3: the kind of attention to detail and looking at the
- 17:45Speaker 3: numbers that's an important success. And then the fact that
- 17:49Speaker 3: you're on medsync again puts you in the top twenty
- 17:53Speaker 3: percent of pharmacies. You know, I continue to run into
- 17:57Speaker 3: pharmacies that just haven't got around to it, tried it
- 18:00Speaker 3: and it didn't like it. And you know, they they
- 18:03Speaker 3: don't understand that there's a fair amount of pain before
- 18:06Speaker 3: you get the reward. And and you know you've experienced that.
- 18:12Speaker 3: And and I love I love your doctors, your doctor's stuff.
- 18:18Speaker 3: I mean, that's such an obvious thing gets talked about
- 18:22Speaker 3: at every trade show. You know, get to get to
- 18:25Speaker 3: know your doctors, get to know your doctors, and and
- 18:29Speaker 3: you know, there is a there is a true fact
- 18:32Speaker 3: about pharmacists when when you take all your tests to
- 18:36Speaker 3: go to pharmacy school, they're they're looking for numbers people,
- 18:40Speaker 3: detail people. And you know, for for most of the pharmacists,
- 18:46Speaker 3: to get him to leave the store and go knock
- 18:48Speaker 3: on a door and ask to see the doctor is
- 18:52Speaker 3: the hardest thing in the world and they never get
- 18:55Speaker 3: around to doing it. And your pathway to doing it
- 18:59Speaker 3: was exception. Everybody's got a detailed man who they can
- 19:02Speaker 3: tag along with. And so I I just love that.
- 19:08Speaker 3: So the real trick here is realizing it's small numbers
- 19:15Speaker 3: but big reward. And the fact of the matter is
- 19:19Speaker 3: somebody's got to convince the doctor to write the prescriptions
- 19:23Speaker 3: for these products that are not in the common lexicon.
- 19:28Speaker 3: Tell me a little bit about how you do that.
- 19:31Speaker 5: Well, we're fortunate, so this company is small, so they
- 19:36Speaker 5: only have a limited amount of drug reps.
- 19:39Speaker 4: What I would tell people that may not have a
- 19:41Speaker 4: drug rep in their area, You guys, you don't understand
- 19:46Speaker 4: the power of your opinion. Or these docs are absolutely
- 19:53Speaker 4: starving for relationships, is what I've found out. I haven't
- 19:57Speaker 4: been into a doctor's office yet, or I haven't within
- 20:01Speaker 4: a week generated another two to three patients that they
- 20:04Speaker 4: pushed over. Or I always tell them, you know, and
- 20:08Speaker 4: some of you guys may not want the oh, the work,
- 20:12Speaker 4: or the effort or the pain, but you know, I
- 20:15Speaker 4: tell them, give me, give me your give me your
- 20:17Speaker 4: hardest patient or the one that's your biggest pain in
- 20:20Speaker 4: the button.
- 20:21Speaker 5: Let me deal with them, because we're a lot.
- 20:23Speaker 4: Of times these people they're just they've been to Walgreens
- 20:26Speaker 4: enough and nobody's listening. In the independent world, we have
- 20:29Speaker 4: time to listen for at least thirty seconds to two minutes,
- 20:34Speaker 4: and sometimes the patients all they don't have anybody at home,
- 20:37Speaker 4: or they don't have anybody to talk to, or you know,
- 20:41Speaker 4: I don't know they're depressed or so. There's so many
- 20:44Speaker 4: societal factors anymore that go into this. Sometimes they just
- 20:47Speaker 4: want to be talked to somebody and be heard, and
- 20:50Speaker 4: if you just listen, that goes a long way. Yeah,
- 20:54Speaker 4: they can be annoying and maybe they take five minutes
- 20:57Speaker 4: instead of two minutes.
- 20:58Speaker 5: But that being said, it is still potential more scripts.
- 21:02Speaker 5: And with potential, the numbers never lie. I call them
- 21:09Speaker 5: heavy hitters. Within you know, one hundred scripts, there may
- 21:12Speaker 5: be two to three heavy hitters, and two to three
- 21:14Speaker 5: heavy hitters can absolutely lift your entire profit margin across
- 21:20Speaker 5: the board.
- 21:21Speaker 4: You you know, you throw a couple thousand dollars revenue
- 21:26Speaker 4: generators off one hundred scripts. That lifted you quite a
- 21:30Speaker 4: bit across your average profit margin line. So I mean,
- 21:34Speaker 4: I I would just tell pharmacists don't be afraid to
- 21:37Speaker 4: go in and talk about it and take a chance.
- 21:39Speaker 5: You're dealing with.
- 21:40Speaker 4: A lot your you know, yeah, it's a little less
- 21:42Speaker 4: talent on it's a little easier on your liver. It's
- 21:47Speaker 4: it is a different drug. It will take a little
- 21:49Speaker 4: effort to get the PA approved. Now, I will tell everybody.
- 21:52Speaker 4: Everybody's probably sitting there listening while the duo eligible. They'll
- 21:57Speaker 4: they'll approve about anything. We have people on Human that
- 22:01Speaker 4: have gotten approved. We have people on CBS. Now CBS,
- 22:04Speaker 4: I could go into a different speech on that. That's
- 22:08Speaker 4: they've got some shenanigans they like to pull. We have Optum,
- 22:12Speaker 4: we have Blue Cross, Blue Shield. We have basically almost
- 22:17Speaker 4: every one of the We do have some e SI
- 22:20Speaker 4: or express scripts optums. The main one are United Healthcare.
- 22:25Speaker 4: But yeah, again they all pay very very well.
- 22:28Speaker 5: But again I just can't stress this enough.
- 22:32Speaker 4: Just go have a conversation with the doctor and tell
- 22:35Speaker 4: them what you're and also I am very upfront about Hey,
- 22:40Speaker 4: they'll ask me, well, what's going on with this? Well
- 22:42Speaker 4: two things, and I will give three patients that are
- 22:46Speaker 4: real life stories. Number one, I'll tell you. I'll tell
- 22:48Speaker 4: the doctor, yes, I do make way better money than
- 22:52Speaker 4: a percoset. And they're like, okay, that's fine that they
- 22:55Speaker 4: understand that you need to make money because if you
- 22:57Speaker 4: don't make money, you're not in business and you can't
- 22:59Speaker 4: ultimately help people or be around to help the doctor.
- 23:03Speaker 4: Number two Weirdly, this drug is a is a branded medication,
- 23:09Speaker 4: so it's got a little more pop in it. That
- 23:13Speaker 4: being said, I have three patients that actually came to
- 23:17Speaker 4: me and said, Jed, this actually has a little too
- 23:19Speaker 4: much juice in it.
- 23:21Speaker 5: Is it okay if I cut the pill?
- 23:23Speaker 4: And I said absolutely, And they're like okay, And I said,
- 23:27Speaker 4: do me a favor, though, make sure you get in
- 23:29Speaker 4: your doctor's portal and tell your doctor you're cutting the pill,
- 23:33Speaker 4: because they're going to be elated to hear this. Sure enough,
- 23:36Speaker 4: they got the portal and told the doctor, and the
- 23:40Speaker 4: doctor actually reduced their mmes because they just were And
- 23:44Speaker 4: I'm not saying it's a miracle drug and it's the
- 23:46Speaker 4: greatest drug, and we do twenty patients of roughly twenty
- 23:50Speaker 4: patients a month.
- 23:51Speaker 5: But when you can go to a.
- 23:52Speaker 4: Doctor and cut the pill and you've got a guy
- 23:56Speaker 4: that's been on a pain medication or percocet for fifteen
- 23:58Speaker 4: to twenty years and reducing his mmes, that means something
- 24:02Speaker 4: to the doctor and it gains a lot of report So.
- 24:05Speaker 3: Well, yeah, well I changed the subject real quick. I
- 24:09Speaker 3: know that you had a chance to go with the
- 24:12Speaker 3: FH two Pharma team to the Pharmacy Profit summit in
- 24:17Speaker 3: Dallas a couple of weeks the Leasa Foust program. Tell
- 24:21Speaker 3: us a little bit about how that worked and what
- 24:24Speaker 3: was your reception there.
- 24:26Speaker 5: Well, it actually was.
- 24:28Speaker 4: It was fun because I've always wanted I've never been again.
- 24:32Speaker 4: I've been doing the independent pharmacy thing for oh. I
- 24:37Speaker 4: got my anniversary coming up this weekend and we got
- 24:40Speaker 4: so thirteen years now, and we we were we had
- 24:48Speaker 4: one store and we bought the telefarm store bought it
- 24:51Speaker 4: was an actual pharmacy.
- 24:53Speaker 5: We were absolutely nothing to begin with. Resources were limited.
- 24:57Speaker 4: We we we barely had a pot to piss and
- 25:02Speaker 4: pardon my French, so we were always looking for new
- 25:06Speaker 4: ways to generate script volume revenue. I never had a
- 25:10Speaker 4: chance to go to the pharmacy profit. I had colleagues
- 25:13Speaker 4: that were in the area that were bigger independence that
- 25:15Speaker 4: I would I call it stealing, but they would go
- 25:18Speaker 4: and they tell me the stories and what the new
- 25:22Speaker 4: things were, and this is the direction that maybe the
- 25:24Speaker 4: company or the industry's going.
- 25:25Speaker 5: Blah blah blah blah blah.
- 25:27Speaker 4: Well I got a chance to go down there, and
- 25:29Speaker 4: what what what kind of intrigued me was you had
- 25:34Speaker 4: a whole bunch of like minded people that were looking
- 25:36Speaker 4: to try new things.
- 25:38Speaker 5: They were they were all in the same boat.
- 25:40Speaker 4: Everybody I talked to, and I talked to close to
- 25:42Speaker 4: seventy five to one hundred people. They were all looking for,
- 25:47Speaker 4: you know, different ways to earn or trying to find
- 25:50Speaker 4: out what the new hot thing was.
- 25:51Speaker 5: You know.
- 25:53Speaker 4: One of the things was, you know, different NDCs on
- 25:55Speaker 4: certain drugs. You know, I obviously had higher reimbursements some
- 26:00Speaker 4: of the pharmacy softwares that could maybe tease out some
- 26:04Speaker 4: of your mind your own data that would find high reimbursements.
- 26:07Speaker 4: But talking to the people at first, you know, they
- 26:11Speaker 4: would walk by the booth and they'd kind of stop
- 26:13Speaker 4: and look and they're like, well that's oxy. And then
- 26:17Speaker 4: you know, I would come explain what we were doing,
- 26:19Speaker 4: exactly what I just did to you, and everybody wanted
- 26:22Speaker 4: to learn more. So we had a lunch in where
- 26:24Speaker 4: I had a table and I think I had you know,
- 26:27Speaker 4: twenty fifteen to twenty people come by and really dive
- 26:30Speaker 4: into the data. So I did have one lady call
- 26:35Speaker 4: me out. She goes, well, this is probably old data
- 26:37Speaker 4: from a couple of years ago.
- 26:38Speaker 5: And I told her Man. The script was filled three
- 26:41Speaker 5: days ago.
- 26:41Speaker 4: So yeah, it went really well, at least I thought
- 26:48Speaker 4: it did. You'd have to talk to the FH two boys.
- 26:52Speaker 4: But I learned as much from others as I did.
- 26:59Speaker 4: Hopefully they learn from me, because also you you were
- 27:02Speaker 4: in a in a room with a bunch of people
- 27:04Speaker 4: that were, you know, trying new things.
- 27:06Speaker 2: Uh.
- 27:07Speaker 5: And I love to talk to people about what is working?
- 27:11Speaker 5: What have you tried? And maybe it didn't work or
- 27:13Speaker 5: how did.
- 27:13Speaker 4: You maybe maybe didn't give it enough time or you know,
- 27:18Speaker 4: I call them, we call them learning scars in our company.
- 27:21Speaker 4: Sometimes you try things, it may work, sometimes it doesn't.
- 27:25Speaker 4: You get cut. Sometimes the cuts are deeper than others
- 27:29Speaker 4: and you look back and you're like, oh, don't do
- 27:32Speaker 4: that again.
- 27:32Speaker 5: That really that scar. That hurt.
- 27:35Speaker 3: So but everybody back to your boat analogy. You hit
- 27:41Speaker 3: a sandbar, you back up, and you go around. Yeah.
- 27:45Speaker 5: Yeah, correct, So well that's great.
- 27:49Speaker 3: So, I mean, I guess the last question is is
- 27:54Speaker 3: this a uh splash in the night or what's the cliche?
- 27:59Speaker 3: I mean you I think there's some legs on this thing.
- 28:02Speaker 5: Yeah, you know, I wrestle with that. I go back
- 28:05Speaker 5: and forth every year.
- 28:06Speaker 4: You know, every pharmacy has what I call heavy hares,
- 28:11Speaker 4: high profit drugs. Nobody talks about those drugs, you know,
- 28:14Speaker 4: And that's what I found out down at that pharmacy.
- 28:16Speaker 4: Profit people are willing to share their their high margin
- 28:20Speaker 4: drugs or what they were doing that what they were
- 28:22Speaker 4: winning at. Yeah, you have losers, but you know there's
- 28:26Speaker 4: numbers in volume as long as you're channeling it in
- 28:29Speaker 4: the right direction. Now that being said, every year January
- 28:36Speaker 4: one is always you know, nerve wracking because you're dealing
- 28:41Speaker 4: with new PA's, you've got new Medicare plans.
- 28:44Speaker 5: You know, we do, we do.
- 28:45Speaker 4: We channel a lot of energy into putting people in
- 28:48Speaker 4: the right plans or trying to put people in the
- 28:50Speaker 4: right plans to help them but also help us. So
- 28:57Speaker 4: you're always worried about it if that if the PE
- 29:00Speaker 4: is going to catch you up or they're going to
- 29:01Speaker 4: shut you down or change some things.
- 29:04Speaker 5: We've been doing this.
- 29:05Speaker 4: We've been through two January ones now and we've we've
- 29:09Speaker 4: actually not we've had a continuation of care on all
- 29:12Speaker 4: of our patients. Now we've lost a couple just because
- 29:16Speaker 4: you know they've went off the drug completely. They may
- 29:19Speaker 4: have expired, you know, I had a couple of people
- 29:20Speaker 4: that are eighty plus years old that have just expired.
- 29:23Speaker 5: That happens.
- 29:24Speaker 4: We've also got some new ones that have come into
- 29:26Speaker 4: the fold. But to say it's going to die, no,
- 29:32Speaker 4: the only thing that we've ran into that would be
- 29:35Speaker 4: a hurdle. I would say a hurdle is and some
- 29:38Speaker 4: of these other people I probably know exactly what I'm
- 29:40Speaker 4: talking about when I discussed this, but CBS has this
- 29:45Speaker 4: and I can't remember with adherent or they've got a
- 29:48Speaker 4: word for it of borring. I think it's the inherent
- 29:53Speaker 4: drugg list LI where you're making too much money on
- 29:58Speaker 4: And I tell Buddy, if I had Bezos or Musk
- 30:02Speaker 4: or any of those guys, I would get a legal
- 30:05Speaker 4: team and I would absolutely bury CBS. I have a
- 30:13Speaker 4: unique background where I had an uncle who brought me
- 30:16Speaker 4: up and he started a PBM and he was the
- 30:18Speaker 4: ninth largest PBM in the country and they did really well,
- 30:22Speaker 4: and so I got some unique knowledge on how the
- 30:25Speaker 4: PBUM works. That being said carving in cherry pick and saying, wow,
- 30:29Speaker 4: you're making too much money here. They forced you to
- 30:32Speaker 4: run the brand where they where they only pay you
- 30:35Speaker 4: two hundred dollars over costs versus roughly fifteen hundred dollars
- 30:40Speaker 4: cost over the gNire.
- 30:42Speaker 5: I just find I just find it laughable. Can I
- 30:44Speaker 5: go through.
- 30:45Speaker 4: Their you know data, they Well, you guys are charging
- 30:50Speaker 4: this company too much.
- 30:51Speaker 5: You actually should charge him this. I mean it's BS so.
- 30:56Speaker 3: It's certainly not fair and it's not a level plane field.
- 31:00Speaker 3: And my gosh, Mark Cuban is the guy with the
- 31:04Speaker 3: money who needs to do this. Hey, Jed, I've had
- 31:08Speaker 3: a lot of fun. I've certainly learned a lot, and
- 31:11Speaker 3: I appreciate your candor and your willingness to share with
- 31:15Speaker 3: others this product and this program. The company is f
- 31:22Speaker 3: H two Pharma, and that's wwww the three ws F.
- 31:29Speaker 3: F H two F is in frank h is in Henry.
- 31:33Speaker 3: Two is in the number two, and it's pharma the
- 31:38Speaker 3: class equay you spell it. But it is dot net
- 31:41Speaker 3: not dot com, and you should be able to find
- 31:44Speaker 3: out about it. The one last thing I'll say is
- 31:47Speaker 3: I got acquainted with the company through a longtime industry
- 31:51Speaker 3: friend by the name of Matt Phillips, who about a
- 31:54Speaker 3: year ago came on to be the general manager for
- 31:57Speaker 3: this company. And I know Matt be a guy of
- 32:00Speaker 3: integrity and immense experience in the pharma business. And I
- 32:05Speaker 3: know one of the things that the company does is
- 32:08Speaker 3: constantly research for new new products that fit into these tweeners,
- 32:15Speaker 3: as you say, and when they get eclipsed or taken off,
- 32:20Speaker 3: they have the ability to find a way to bring
- 32:24Speaker 3: another one. So you know they're well aware of this
- 32:27Speaker 3: fact in the industry that you know that none of
- 32:31Speaker 3: these products will be five ten years down the road
- 32:35Speaker 3: without being clamped down at least the way PBMs are now.
- 32:40Speaker 3: So I'm going to say thank you Jed Jed lewis
- 32:44Speaker 3: Medicine Man Pharmacies in Nebraska and brought to you today
- 32:49Speaker 3: by f H two Pharma, and I thank them for
- 32:54Speaker 3: their making introducing us. And I'm going to say goodbye
- 32:59Speaker 3: today from Pharmacy Crossroads. It's been a pleasure chatting with
- 33:04Speaker 3: you all and I hope something we've said here today
- 33:07Speaker 3: will inspire you to do more and be better.
- 33:11Speaker 5: Good day.
- 33:12Speaker 2: Thanks for listening to Pharmacy Crossroads. If you're interested in
- 33:16Speaker 2: talking with Bruce, please contact the show visit Pharmacycrossroads dot com.
- 33:21Speaker 5: We look forward to hearing from you.